Sandoz launches generic Prevpac

PRINCETON, N.J. — Sandoz announced the U.S. launch of lansoprazole capsules amoxicillin capsules, USP, and clarithromycin tablets, USP, the generic version of Prevpac.



The drug is used to eliminate the H. pylori infection in patients with duodenal ulcer disease. It's comprised of amoxicillin and clarithromycin, which are antibiotic medicines, as well as lansoprazole, a proton pump inhibitor that helps decrease production of excess stomach acid, the company said.



“Sandoz is proud to provide a generic version of this important gastro-intestinal therapy,” said Peter Goldschmidt, president of Sandoz. “This launch further expands the Sandoz offering of affordable, high-quality medicines.”



Sandoz will market lansoprazole capsules, amoxicillin capsules, USP, and clarithromycin tablets in the same strengths that Prevpac did. Sales in the United states for branded lansoprazole capsules, amoxicillin capsules, USP, and clarithromycin tablets, USP, totaled approximately $69.7 million for the 12 months ending January 2014, according to IMS Health.